echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Green Valley Pharmaceuticals abolishes the medical insurance negotiating team?

    Green Valley Pharmaceuticals abolishes the medical insurance negotiating team?

    • Last Update: 2021-12-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    It is reported that China's original new drug for the treatment of Alzheimer's disease, Mannite Sodium Capsules (trade name: Nine Phase One®) has been included in the medical insurance for more than half a month.


    There are currently more than 10 million Alzheimer's disease (Alzheimer's disease, also known as Alzheimer's disease) patients in China, and this will accelerate the growth of the population with the aging process, causing extremely heavy social and economic burdens


    Jiu Phase One® is a new type of AD treatment drug.


    Since October 2019, Geng Meiyu’s team published research results related to the mechanism of action of GV-971 (the code used in the study period of Nine Phase One®) in the form of a cover article on "Cell Research".


    According to the "Medical Insurance Catalog (2021)" announced on the 3rd of this month, Nine Phase One® entered the list of 74 new medical insurance drugs.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.